Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia

There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Gajanan, Narayanaswamy, Janardhanan C., Math, Suresh Bada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803/
https://www.ncbi.nlm.nih.gov/pubmed/23112432
http://dx.doi.org/10.4103/0253-7613.100406
_version_ 1782247627546427392
author Kulkarni, Gajanan
Narayanaswamy, Janardhanan C.
Math, Suresh Bada
author_facet Kulkarni, Gajanan
Narayanaswamy, Janardhanan C.
Math, Suresh Bada
author_sort Kulkarni, Gajanan
collection PubMed
description There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug.
format Online
Article
Text
id pubmed-3480803
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-34808032012-10-30 Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia Kulkarni, Gajanan Narayanaswamy, Janardhanan C. Math, Suresh Bada Indian J Pharmacol Drug Watch There are reports of de novo development or exacerbation of obsessive-compulsive symptoms in patients with schizophrenia treated with atypical antipsychotics, although this is widely debated. We report one such case where a patient with a primary diagnosis of schizophrenia, treated with olanzapine, developed de novo obsessive-compulsive disorder, with convincing evidence for its causality due to the drug. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3480803/ /pubmed/23112432 http://dx.doi.org/10.4103/0253-7613.100406 Text en Copyright: © Indian Journal of Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Kulkarni, Gajanan
Narayanaswamy, Janardhanan C.
Math, Suresh Bada
Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
title Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
title_full Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
title_fullStr Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
title_full_unstemmed Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
title_short Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
title_sort olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480803/
https://www.ncbi.nlm.nih.gov/pubmed/23112432
http://dx.doi.org/10.4103/0253-7613.100406
work_keys_str_mv AT kulkarnigajanan olanzapineinduceddenovoobsessivecompulsivedisorderinapatientwithschizophrenia
AT narayanaswamyjanardhananc olanzapineinduceddenovoobsessivecompulsivedisorderinapatientwithschizophrenia
AT mathsureshbada olanzapineinduceddenovoobsessivecompulsivedisorderinapatientwithschizophrenia

Ejemplares similares